![](https://cdn.prod.website-files.com/63e3ec55dd97ccc38545cfe9/63e3ec55dd97cc795a45d2d2_bio.png)
Biosplice Therapeutics
Restore health by delivering first-in-class therapies that harness alternative splicing
Biosplice is developing first-in-class, small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing. Stemming from foundational discoveries in Wnt pathway modulation, Biosplice has elucidated novel biology linking CLK/DYRK kinases to the therapeutic regulation of alternative splicing. Alternative splicing is an essential biological mechanism that regulates the diversification of proteins in a cell, which, in turn, determines cell type and function. Biosplice’s target class governs the selection of tissue-specific mRNA splice sites, making them attractive, druggable targets within the cellular “command and control” center.